Healthcare Startups

One imaging decision that once took two weeks now takes 48 hours. That single number defines why Cambridge's Qureight just closed a $20 million Series B — and why the company's chest foundation model is being watched closely by every pharma…
Read More...

The average credentialing delay costs a medical practice $9,000 in lost revenue per provider, per day — a figure that makes the Assured Health Series A round not just a funding milestone, but a direct attack on one of healthcare's most…
Read More...

In under a year since launch, Bengaluru-based SuperLiving crossed 1.5 million app installs and surpassed 100,000 paying users — with 73% of those paying customers coming from Tier II and Tier III cities. That kind of traction caught serious…
Read More...

Key Takeaways The device: A soft, stretchable skin sticker that delivers beat-to-beat blood pressure data wirelessly, without needles or cuffs Clinical validation: Tested on over 600 patients across ~8 hospitals; matched arterial line…
Read More...

VahatiCor, a medtech company developing interventional therapies for Coronary Microvascular Dysfunction, announced the appointment of Harry D. Rowland, Ph.D., as Chief Executive Officer. The VahatiCor new CEO brings a resume built on…
Read More...

The psychiatric workforce shortage in the United States is severe and worsening — more than 122 million Americans live in federally designated mental health professional shortage areas, according to the Health Resources and Services…
Read More...

Prescription renewals account for roughly 80% of all medication activity in the United States — yet most of those transactions still trap patients in a loop of phone tags, scheduling delays, and administrative friction that can stretch for…
Read More...

The global AI diagnostics market, valued at $1.62 billion in 2024, is projected to reach $8.08 billion by 2032 — and one Paris-based startup just placed a very clear $33 million bet on leading that transformation. Waiv, an Owkin spinout…
Read More...

Tandem AI prescription startup just achieved a remarkable $1 billion valuation, cementing its position among health tech unicorns 2026 and marking a watershed moment for AI in pharmacy innovation. This New York-based company has quietly…
Read More...

The healthcare AI platform OpenEvidence just achieved a staggering OpenEvidence $12 billion valuation following a massive $250 million funding round, catapulting its CEO's net worth to $7.6 billion and signaling a seismic shift in how…
Read More...